Back to Search
MICHAEL LAYNE, MD
MD
Family Medicine Physician
NPI: 1740440536IndividualAccepts Medicare
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
0101251815(VA)
Education
VIRGINIA COMMONWEALTH UNIVERSITY, SCHOOL OF MEDICINE
Class of 2008
Research & Publications (20)
Characterization of the mouse aortic carboxypeptidase-like protein promoter reveals activity in differentiated and dedifferentiated vascular smooth muscle cells.
PMID 11934842·Circ Res·2002
7-preclinical
Role of macrophage-expressed adipocyte fatty acid binding protein in the development of accelerated atherosclerosis in hypercholesterolemic mice.
PMID 11606480·FASEB J·2001
7-preclinical
Impaired abdominal wall development and deficient wound healing in mice lacking aortic carboxypeptidase-like protein.
PMID 11438679·Mol Cell Biol·2001
7-preclinical
Aortic carboxypeptidase-like protein is expressed in fibrotic human lung and its absence protects against bleomycin-induced lung fibrosis.
PMID 19179605·Am J Pathol·2009
7-preclinical
Disruption of striated preferentially expressed gene locus leads to dilated cardiomyopathy in mice.
PMID 19118250·Circulation·2009
4-observational
Netropsin improves survival from endotoxaemia by disrupting HMGA1 binding to the NOS2 promoter.
PMID 18937643·Biochem J·2009
7-preclinical
Transforming growth factor beta up-regulates cysteine-rich protein 2 in vascular smooth muscle cells via activating transcription factor 2.
PMID 18387947·J Biol Chem·2008
7-preclinical
High mobility group A1 protein mediates human nitric oxide synthase 2 gene expression.
PMID 18279675·FEBS Lett·2008
8-other
Discoidin domain receptor 2 impairs insulin-stimulated insulin receptor substrate-1 tyrosine phosphorylation and glucose uptake in 3T3-L1 adipocytes.
PMID 17712722·Horm Metab Res·2007
7-preclinical
Telomerase, myofibroblasts, and pulmonary fibrosis.
PMID 16618786·Am J Respir Cell Mol Biol·2006
7-preclinical
Endotoxin-induced down-regulation of Elk-3 facilitates heme oxygenase-1 induction in macrophages.
PMID 16456000·J Immunol·2006
7-preclinical
Increased neointima formation in cysteine-rich protein 2-deficient mice in response to vascular injury.
PMID 16269651·Circ Res·2005
7-preclinical
Aortic carboxypeptidase-like protein is regulated by transforming growth factor beta in 3T3-L1 preadipocytes.
PMID 15927179·Exp Cell Res·2005
7-preclinical
Aortic carboxypeptidase-like protein is expressed in collagen-rich tissues during mouse embryonic development.
PMID 15749083·Gene Expr Patterns·2005
7-preclinical
Absence of heme oxygenase-1 exacerbates myocardial ischemia/reperfusion injury in diabetic mice.
PMID 15734856·Diabetes·2005
7-preclinical
Reduction of nitric oxide synthase 2 expression by distamycin A improves survival from endotoxemia.
PMID 15356165·J Immunol·2004
4-observational
Pre-emptive gene therapy using recombinant adeno-associated virus delivery of extracellular superoxide dismutase protects heart against ischemic reperfusion injury, improves ventricular function and prolongs survival.
PMID 15029230·Gene Ther·2004
7-preclinical
Absence of heme oxygenase-1 exacerbates atherosclerotic lesion formation and vascular remodeling.
PMID 12958201·FASEB J·2003
7-preclinical
Elk-3 is a transcriptional repressor of nitric-oxide synthase 2.
PMID 12896968·J Biol Chem·2003
7-preclinical
Identification of a CArG-independent region of the cysteine-rich protein 2 promoter that directs expression in the developing vasculature.
PMID 12791591·Am J Physiol Heart Circ Physiol·2003
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 825 FAIRFAX AVE STE 118
NORFOLK, VA 23507 - Phone
- (757) 446-5955
Quick Facts
- NPI
- 1740440536
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 18
- Publications
- 20
Are you this provider?
Claim Your Profile